|
The manufacturer was contacted in reference to the voluntary field safety notice / recall notification related to the sound abatement foam in certain cpap, bipap, and mechanical ventilator devices.This report was related to a dreamstation cpap pro device.The manufacturer received information from the patient alleging nose irritation, skin irritation, respiratory tract irritation, hypersensitivity, inflammatory response, reduced cardiopulmonary reserve, liver disease/toxicity, asthma (new or worsening), and lung disease.Medical intervention was not specified.The manufacturer was made aware of this complaint through a representative of the customer.The device has not yet been returned to the manufacturer for evaluation.If any additional information is received, a follow-up report will be filed.
|
|
The product associated with this complaint was not returned to the manufacturer.However, capa pr 7211 documents the investigation into similar complaints, correction/removal activities have been initiated (refer to h.9), and complaint code trending is reviewed on a periodic basis to evaluate field quality performance, and as an input to risk management activities.Should additional information be received, a supplemental report will be filed.
|